Literature DB >> 18540899

Decreased dopamine D receptor binding in essential blepharospasm.

C Horie1, Y Suzuki, M Kiyosawa, M Mochizuki, M Wakakura, K Oda, K Ishiwata, K Ishii.   

Abstract

OBJECTIVES: The purpose of this study was to investigate whether dopamine D(2) receptor binding was altered in the striatum of essential blepharospasm patients.
METHODS: Striatal dopamine D(2) receptor binding was measured with positron emission tomography and [(11)C]raclopride. We studied eight drug-naive patients with bilateral blepharospasm and eight age-matched normal controls.
RESULTS: The uptake indices in the blepharospasm group were significantly reduced by 11.7% in the caudate (P < 0.005), 11.6% in the anterior putamen (P < 0.0001), and 10.3% in the posterior putamen (P < 0.005) relative to the control group.
CONCLUSIONS: This study indicates decreased dopamine D(2) receptor binding in the entire striatal region of blepharospasm patients. The findings suggest that decreased dopamine D(2) receptor binding might be one of the predisposing factors that leads to the dysfunction of the motor circuit, resulting in the loss of broad inhibition of unwanted movements during an intended movement in blepharospasm patients.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18540899     DOI: 10.1111/j.1600-0404.2008.01053.x

Source DB:  PubMed          Journal:  Acta Neurol Scand        ISSN: 0001-6314            Impact factor:   3.209


  14 in total

Review 1.  Convergent mechanisms in etiologically-diverse dystonias.

Authors:  Valerie B Thompson; H A Jinnah; Ellen J Hess
Journal:  Expert Opin Ther Targets       Date:  2011-12-03       Impact factor: 6.902

2.  Abnormal striatal dopaminergic neurotransmission during rest and task production in spasmodic dysphonia.

Authors:  Kristina Simonyan; Brian D Berman; Peter Herscovitch; Mark Hallett
Journal:  J Neurosci       Date:  2013-09-11       Impact factor: 6.167

Review 3.  Neuroimaging Applications in Dystonia.

Authors:  Kristina Simonyan
Journal:  Int Rev Neurobiol       Date:  2018-10-23       Impact factor: 3.230

4.  A new knock-in mouse model of l-DOPA-responsive dystonia.

Authors:  Samuel J Rose; Xin Y Yu; Ann K Heinzer; Porter Harrast; Xueliang Fan; Robert S Raike; Valerie B Thompson; Jean-Francois Pare; David Weinshenker; Yoland Smith; Hyder A Jinnah; Ellen J Hess
Journal:  Brain       Date:  2015-07-27       Impact factor: 13.501

Review 5.  Animal models for dystonia.

Authors:  Bethany K Wilson; Ellen J Hess
Journal:  Mov Disord       Date:  2013-06-15       Impact factor: 10.338

6.  Striatal dopaminergic dysfunction at rest and during task performance in writer's cramp.

Authors:  Brian D Berman; Mark Hallett; Peter Herscovitch; Kristina Simonyan
Journal:  Brain       Date:  2013-10-21       Impact factor: 13.501

7.  Twelve cases of drug-induced blepharospasm improved within 2 months of psychotropic cessation.

Authors:  Yuko Emoto; Hirofumi Emoto; Eriko Oishi; Syunichi Hikita; Masato Wakakura
Journal:  Drug Healthc Patient Saf       Date:  2011-06-03

8.  Animal models for investigating benign essential blepharospasm.

Authors:  Craig Evinger
Journal:  Curr Neuropharmacol       Date:  2013-01       Impact factor: 7.363

9.  Differential expression of striatal proteins in a mouse model of DOPA-responsive dystonia reveals shared mechanisms among dystonic disorders.

Authors:  Maria A Briscione; Ashok R Dinasarapu; Pritha Bagchi; Yuping Donsante; Kaitlyn M Roman; Anthony M Downs; Xueliang Fan; Jessica Hoehner; H A Jinnah; Ellen J Hess
Journal:  Mol Genet Metab       Date:  2021-06-02       Impact factor: 4.204

10.  Altered brain activation in a reversal learning task unmasks adaptive changes in cognitive control in writer's cramp.

Authors:  Kirsten E Zeuner; Arne Knutzen; Oliver Granert; Simone Sablowsky; Julia Götz; Stephan Wolff; Olav Jansen; Dirk Dressler; Susanne A Schneider; Christine Klein; Günther Deuschl; Thilo van Eimeren; Karsten Witt
Journal:  Neuroimage Clin       Date:  2015-11-23       Impact factor: 4.881

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.